Scientists Discover Glutathione as an Unexpected Food Source for Tumors

Researchers at the University of Rochester have identified glutathione, a naturally occurring antioxidant, as a nutrient that cancer cells actively consume to fuel their growth. This discovery, published in the journal Nature, reveals a previously unknown mechanism by which tumors obtain energy and opens fresh avenues for developing treatments that could block this process.

How Cancer Cells Use Glutathione as Fuel

Glutathione is best known for its role in protecting cells from oxidative damage and supporting detoxification processes in the body. However, a team led by Dr. Isaac Harris at the Wilmot Cancer Institute found that in the nutrient-poor environment surrounding tumors, cancer cells have adapted to break down glutathione and use it as a source of fuel.

“Cancer cells and normal cells potentially use different food sources,” Dr. Harris explained. “We discovered how cancer cells, specifically, break down this antioxidant and use it as fuel.” This insight shifts the scientific understanding of glutathione from solely a protective molecule to one that can too support tumor metabolism under certain conditions.

Implications for Cancer Treatment

The finding suggests that inhibiting cancer cells’ ability to access or metabolize glutathione could be a viable strategy to slow or stop tumor growth. Due to the fact that glutathione is widely available in the body and commonly taken as a dietary supplement, researchers caution that any therapeutic approach must carefully target tumor-specific pathways without disrupting glutathione’s essential functions in healthy tissues.

“Maybe we need to re-examine the pantry that cancer relies on and look at things that we never thought could actually be used as food for tumors,” Dr. Harris said. “There are additional complex metabolites that others are looking at, so we’re potentially opening a whole new interest into how cancer cells acquire nutrients and how to block that activity.”

About the Research

The study was conducted by Isaac Harris, PhD, along with co-corresponding and co-first authors Fabio Hecht, PhD, and Marco Zocchi, PhD, from the Department of Biomedical Genetics at the University of Rochester Medical Center. Their work builds on earlier investigations into how diet and metabolism influence cancer progression, including prior research on how whole-food plant-based diets may reduce pro-tumor nutrient availability.

The research was supported by the Wilmot Cancer Institute and published in Nature, a leading peer-reviewed scientific journal. Further studies are underway to explore drugs or dietary interventions that could interfere with glutathione utilization in cancer cells while preserving its protective roles elsewhere in the body.

Key Takeaways

• Glutathione, an antioxidant made naturally in the body and sold as a supplement, is used by cancer cells as a nutrient source.
• Tumors break down glutathione to fuel their growth in environments where other nutrients are scarce.
• This discovery reveals a new metabolic pathway that could be targeted to develop novel cancer therapies.
• Any treatment strategy must distinguish between tumor and healthy cell glutathione use to avoid harmful side effects.

Frequently Asked Questions

What is glutathione?

Glutathione is a tripeptide antioxidant composed of the amino acids glutamine, cysteine, and glycine. It is produced naturally in the liver and plays a critical role in neutralizing free radicals, supporting immune function, and detoxifying harmful substances.

Should people stop taking glutathione supplements because of this research?

No. The research does not suggest that glutathione supplementation causes or worsens cancer in healthy individuals. Instead, it highlights how cancer cells may hijack the body’s own metabolites. Anyone considering changes to supplement use should consult their healthcare provider, especially those with a history of cancer or undergoing treatment.

How soon could this lead to new cancer treatments?

While the discovery is promising, translating it into safe and effective therapies will require further preclinical and clinical research. Scientists must first identify ways to block glutathione use in tumors without affecting its vital functions in normal cells.